Myelofibrosis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Myelofibrosis Classification and external resources | |
| Bone marrow: Myelofibrosis: High mag H&E excellent example of myelofibrosis. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | C94.5, D47.1 |
| ICD-9 | 289.89 |
| ICD-O: | 9932, 9961 |
| DiseasesDB | 8616 |
| MeSH | D009191 |
|
WikiDoc Resources for Myelofibrosis | |
|
Articles | |
|---|---|
|
Most recent articles on Myelofibrosis Most cited articles on Myelofibrosis | |
|
Media | |
|
Powerpoint slides on Myelofibrosis | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Myelofibrosis at Clinical Trials.gov Trial results on Myelofibrosis Clinical Trials on Myelofibrosis at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Myelofibrosis NICE Guidance on Myelofibrosis
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Myelofibrosis Discussion groups on Myelofibrosis Patient Handouts on Myelofibrosis Directions to Hospitals Treating Myelofibrosis Risk calculators and risk factors for Myelofibrosis
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Myelofibrosis | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Myelofibrosis with myeloid metaplasia, also known as agnogenic myeloid metaplasia, chronic idiopathic myelofibrosis, and primary myelofibrosis,[1] was first described in 1879 and is currently classified as a myeloproliferative disease caused by the growth and proliferation of an abnormal bone marrow stem cell, resulting in the replacement of the bone marrow with fibrous connective tissue. An eponym for the disease is Heuck-Assmann disease, or Assmann's Disease.
Presentation
The bone marrow is replaced by collagen fibrosis, impairing the patient's ability to generate new blood cells resulting in a progressive anemia. It is usually reactive following other myeloproliferative disorders, such as polycythemia rubra vera or essential thrombocytosis. Extramedullary hematopoeisis occurs as the haemopoetic cells migrate away from the bone marrow, to the liver and spleen. Patients often have hepatosplenomegaly and poikilocytosis. The mean survival is 5 years and causes of death include infection, bleeding, organ failure, portal hypertension, and leukemic transformation.
Diagnosis
Diagnosis is based upon:
- Normochromic normocytic anaemia
- Red cell poikilocytosis on blood film (tear drop RBCs)
- JAK 2 mutation on Val 617 Phe locus in 50%
- Raised lactate dehydrogenase
- Raised neutrophil alkaline phosphatase score
- Bone marrow biopsy may show increased cellularity and fibrosis
References
WikiDoc Research Resources for Myelofibrosis (Click show to right to view) | |
|---|---|
| Articles on Myelofibrosis | Most recent articles on Myelofibrosis • Most cited articles on Myelofibrosis • Review articles on Myelofibrosis • Articles on Myelofibrosis in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Myelofibrosis | Powerpoint slides on Myelofibrosis • Images of Myelofibrosis • Photos of Myelofibrosis • Podcasts & MP3s on Myelofibrosis • Videos on Myelofibrosis |
| Evidence Based Medicine Regarding Myelofibrosis | Cochrane Collaboration on Myelofibrosis • Bandolier on Myelofibrosis • TRIP on Myelofibrosis |
| Cost Effectiveness of Myelofibrosis | Cost Effectiveness of Myelofibrosis |
| Clinical Trials Involving Myelofibrosis | Ongoing Trials on Myelofibrosis at Clinical Trials.gov • Trial results on Myelofibrosis • Clinical Trials on Myelofibrosis at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Myelofibrosis | US National Guidelines Clearinghouse on Myelofibrosis • NICE Guidance on Myelofibrosis • NHS PRODIGY Guidance • FDA on Myelofibrosis • CDC on Myelofibrosis |
| Textbook Information on Myelofibrosis | Books and Textbook Information on Myelofibrosis |
| Pharmacology Resources on Myelofibrosis | Dosing of Myelofibrosis • Drug interactions with Myelofibrosis • Side effects of Myelofibrosis • Allergic reactions to Myelofibrosis • Overdose information on Myelofibrosis • Carcinogenicity information on Myelofibrosis • Myelofibrosis in pregnancy • Pharmacokinetics of Myelofibrosis • |
| Genetics, Pharmacogenomics, and Proteinomics of Myelofibrosis | Genetics of Myelofibrosis • Pharmacogenomics of Myelofibrosis • Proteomics of Myelofibrosis |
| Newstories on Myelofibrosis | Myelofibrosis in the news • Be alerted to news on Myelofibrosis • News trends on Myelofibrosis |
| Commentary on Myelofibrosis | Blogs on Myelofibrosis |
| Patient Resources on Myelofibrosis | Patient resources on Myelofibrosis • Discussion groups on Myelofibrosis • Patient Handouts on Myelofibrosis • Directions to Hospitals Treating Myelofibrosis • Risk calculators and risk factors for Myelofibrosis |
| Healthcare Provider Resources on Myelofibrosis | Symptoms of Myelofibrosis • Causes & Risk Factors for Myelofibrosis • Diagnostic studies for Myelofibrosis • Treatment of Myelofibrosis |
| Continuing Medical Education (CME) Programs on Myelofibrosis | CME Programs on Myelofibrosis |
| International Resources on Myelofibrosis | Myelofibrosis en Espanol • Myelofibrosis en Francais |
| Business Resources on Myelofibrosis | Myelofibrosis in the Marketplace • Patents on Myelofibrosis |
| Informatics Resources on Myelofibrosis | List of terms related to Myelofibrosis |
de:Osteomyelofibrose fr:Splénomégalie myéloïde it:Mielofibrosi
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

